Carcinoembryonic antigen as a vaccine target.
We seek to understand and harness our immune systems almost to the same degree as we have sought the answers of the universe. It is gratifying to see that we are making progress in this area with the result being evidence of clinical benefit and consistent alterations in the immune response. In this review, we will explore just one aspect of our efforts by focusing on vaccines that target carcinoembryonic antigen.
Wang
Dongmei
D
National Cancer Institute, 10 Center Drive, Building 10, Room 12 N226, Bethesda, MD 20892, USA. wangdong@mail.nih.gov
Rayani
Shayan
S
Marshall
John L
JL